Piper Jaffray comments on speculation Gen-Probe (Nasdaq: GPRO) could buy the remaining half of Chiron's (Nasdaq: CHIR) blood testing business ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE